Damora Therapeutics grants options for 120,900 shares to five new employees
DMRA•Damora Therapeutics granted options to purchase 120,900 ordinary shares to five newly hired, non-executive employees on November 1, 2026. The options have a 10-year term and an exercise price of $21.49 per share.
1. Option grant terms
The options vest 25% on each employee's first start-date anniversary, with the remainder vesting in equal monthly installments over 36 months.
